OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations

Milestone use of OrthoPediatrics’ PNP Tibia system signals strong early adoption and sets up a broader European rollout in 2027.

Rhea-AI Summary

OrthoPediatrics (KIDS) reports more than 1,000 implantations of its PNP Tibia Nail system in pediatric patients as of September 22, 2026.

The system features a 7mm cannulated rigid tibial nail, described as the only product of its size, with implants available in 7mm–12mm diameters. Nearly 20% of all OrthoPediatrics tibia nails implanted have been the smallest 7mm size. PNP Tibia is currently offered in five markets, with a European launch planned for 2027.

Positive

• Over 1,000 PNP Tibia nails implanted in pediatric patients
• ~20% of implanted nails are the smallest 7mm size
• PNP Tibia available in five markets, with Europe launch planned for 2027

Negative

• None.

Market Context

At publication, KIDS had closed at $22.35 pre-headline; the 1,000th PNP Tibia implantation marked ad...

Analysis

At publication, KIDS had closed at $22.35 pre-headline; the 1,000th PNP Tibia implantation marked adoption in Trauma & Deformity, the segment that reported $52.6 million of second-quarter sales before a 6.85% 24-hour price reaction.

Key Figures

Tibia Nail Implantations: 1,000 implantations 7mm Nail Adoption: Nearly 20% Smallest Nail Diameter: 7mm +3 more

Tibia Nail Implantations

1,000 implantations

PNP Tibia System milestone

7mm Nail Adoption

Nearly 20%

Share of OrthoPediatrics nails implanted

Smallest Nail Diameter

7mm

PNP Tibia System

Available Nail Diameters

7mm-12mm

PNP Tibia System

Current Market Availability

Five markets

PNP Tibia System

European Launch

2027

Planned PNP Tibia System launch

Historical Context

1 past event · Latest: Aug 04

1 event

1. Aug 04

   Earnings report

   24h Move

   +6.8%

   Trauma & Deformity sales rose 26% to $52.6 million in second-quarter results

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

cannulated, intramedullary canal, suprapatellar

3 terms

cannulated technical

"introduction of the 7mm cannulated rigid tibial nail"

Cannulated describes a medical instrument, implant, or anatomical structure that has a hollow center or has had a thin tube (a cannula) inserted into it. Think of a straw or hollow bolt: the opening lets surgeons pass guidewires, fluids, or other tools through the device or access a body channel without removing surrounding parts. Investors see this term in filings and product descriptions because cannulation affects how a device is used, how procedures are performed, and can influence clinical adoption, manufacturing complexity, and regulatory claims.

intramedullary canal medical

"small instruments to access the intramedullary canal"

The intramedullary canal is the hollow, central cavity inside a long bone that normally contains bone marrow and runs along the bone’s length, like the core of a filled tube. It matters to investors when medical devices, such as orthopedic rods, nails, or stems, are designed to sit inside that space because fit, fixation, and biological response in the canal affect device performance, surgical complexity, regulatory review, and clinical outcomes.

suprapatellar medical

"instrumentation supporting both traditional and suprapatellar approaches"

An anatomical term meaning 'above the patella' — the area or structures located just over the kneecap. It commonly describes tissues, bursae, pouches, surgical approaches, or implants in the upper front part of the knee; think of it as the space directly above a lid (the kneecap). Investors see the term in clinical trial results, device descriptions, or procedure summaries because it specifies the exact part of the knee being treated or studied.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the recent implantation of the 1,000^th Tibia Nail using its latest Pediatric Nailing Platform (PNP).

The PNP Tibia System was designed to bring a world-class, pediatric-focused nailing system to surgeons, enabling the use of rigid tibial nails in pediatric patients.

OrthoPediatrics’ introduction of the 7mm cannulated rigid tibial nail, the only product of its size, enables surgeons to treat patients who have previously been untreatable with adult systems. In fact, nearly 20% of all nails implanted by OrthoPediatrics have been the smallest 7mm size available. The implant is available in 7mm-12mm diameters.

Joe Hauser, President of Trauma & Deformity, stated, “The rapid adoption of this system demonstrates that OrthoPediatrics is filling a critical void in implant offerings to our core customer. The surgeon design team and our OrthoPediatrics engineers were meticulous in developing a system purpose-built for the needs of pediatric patients, and it is proving to be a valuable tool in treating over 1,000 kids with tibia fractures.”

The system includes small instruments to access the intramedullary canal, smaller overall nails, fixation options designed to avoid the physis, and instrumentation supporting both traditional and suprapatellar approaches.

PNP Tibia is currently available in five markets, with a European launch planned for 2027.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 90 systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.

Investor Contact
Philip Taylor
Gilmartin Group
philip@gilmartinir.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What design features differentiate the PNP Tibia system for pediatric use?

The PNP Tibia system includes a 7mm cannulated rigid tibial nail available in 7mm–12mm diameters and small instruments to access the intramedullary canal. It also offers smaller overall nails, fixation options designed to avoid the physis, and instrumentation that supports both traditional and suprapatellar approaches.

How does the 7mm PNP Tibia nail expand treatment options?

The company states that its 7mm cannulated rigid tibial nail, described as the only product of its size, enables surgeons to treat pediatric patients who could not previously be treated with adult tibial nailing systems.